However, abundant evidence shows that cooking with a gas stove releases pollutants that harm human health. Multiple studies ...

Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

The MHRA has approved depemokimab as an add-on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

December 16 is National Chocolate-Covered Anything Day, which is either a celebration of culinary creativity or an excuse to ...

In today’s ACT Brief, we look at emerging operational changes aimed at reducing site burden, review the FDA approval of GSK’s ...

The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for ...

With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. | On ...

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

A recent study reveals a worrying connection between mental health disorders like depression and anxiety, and an increased susceptibility to asthma in adults.

The parents of a 13-year-old girl who died after an asthma attack led to a cardiac arrest have said they fear "other families ...